- 专利标题: Treatment of obesity and essential hypertension and related disorders
-
申请号: US737794申请日: 1991-07-18
-
公开(公告)号: US5280014A公开(公告)日: 1994-01-18
- 发明人: Garth J. S. Cooper , Brendan Leighton
- 申请人: Garth J. S. Cooper , Brendan Leighton
- 申请人地址: CA San Diego
- 专利权人: Amylin Pharmaceuticals, Inc.
- 当前专利权人: Amylin Pharmaceuticals, Inc.
- 当前专利权人地址: CA San Diego
- 主分类号: A61K38/00
- IPC分类号: A61K38/00 ; A61K38/22 ; C07K14/575 ; C07K16/26 ; A61K37/02 ; C07K7/10
摘要:
The administration of antagonists and blockers of amylin or CGRP or both for the treatment of obesity and essential hypertension and associated lipid disorders and atherosclerosis.
公开/授权文献
- US5870528A Automatic MDF apparatus 公开/授权日:1999-02-09
信息查询
IPC分类: